Recombinant Von Willebrand factor concentrate in 2A Von Willebrand disease: comparison to plasma-derived Von Willebrand factor concentrate therapy

Rajpurkar, M; Frey, MJ; Sabo, C; Hollon, W

Rajpurkar, M (reprint author), Childrens Hosp Michigan, Carman & Ann Adams Dept Pediat, 3901 Beaubien St, Detroit, MI 48201 USA.

BLOOD COAGULATION & FIBRINOLYSIS, 2019; 30 (4): 168

Abstract

Type 2A sub-type of Von Willebrand disease (VWD) is characterized by the loss of high molecular weight multimers. Several plasma-derived Von Willebran......

Full Text Link